S100A9 and early-onset autosomal dominant Alzheimer disease: Concerning Alzheimer's disease, Contini et al. reported higher levels of S100A8, S100A9, α-defensins, and cystatins A and B in patients with Alzheimer's disease compared with healthy volunteers [31].